Table 5 Clinical characteristics of baseline patients in the high-risk group and low-risk group (perforin)
Baseline characteristics | High-risk group (n = 15) | Low-risk group (n = 16) | P |
|---|---|---|---|
Sex (male: female) | 11:4 | 13:3 | 0.598 |
Age (years) | 62 (47–83) | 59 (37–71) | 0.634 |
Child–pugh (5:6) | 13:2 | 14:2 | 0.641 |
TBIL (µmol/L) | 17.4 (8.6–26.5) | 16.1 (6.1–37.1) | 0.453 |
AIB (g/L) | 39 (33.6–44.5) | 40.1 (32.9–48.7) | 0.384 |
PLT (× 109/L) | 128 (59–319) | 163 (80–232) | 0.038 |
PTA (%) | 86.7 (71–104) | 87.6 (69–108) | 0.937 |
Etiology (HBV) | HBV (100%) | HBV (100%) |  > 0.999 |
Diameter of HCC (mm) | 22.7 (9–40) | 19.5 (9–39) | 0.302 |
AFP (ng/ml) | 65.0 (2.33–818) | 1129.5 (1.55–17,694) | 0.359 |
BCLC staging | A (100%) | A (100%) |  > 0.999 |
HBV-DNA (copies/ml) | 709.0 (10–8015) | 55.3 (10–253) | 0.220 |